Comprehensive Cholesterol Test Can Help Identify Patients At Risk of Heart
Disease and Diabetes
BIRMINGHAM, Ala., Aug. 12 /PRNewswire/ -- Atherotech, Inc., a cardio-diagnostic company, today announced that the largest private insurers in Florida as well as Medicare, Medicaid and the Federal Employees Health Benefits (FEHB) Program now cover the VAP(R) (Vertical Auto Profile) Test, the most comprehensive cholesterol test available. That means 9 million more insured lives in Florida now have insurance coverage for the VAP Test, which finds a far greater number of people at risk than the standard cholesterol test.
"The routine lipid panel, which measures total cholesterol, HDL, and triglycerides and calculates LDL, has been shown to have a 40-percent predictive value for coronary heart disease (CHD)," said Paul Ziajka, M.D., Ph.D., director of The Florida Lipid Institute in Winter Park, Fla. "The VAP Test provides twice the predictive ability in indentifying CHD risk compared with traditional lipid panels."
People with a family history or an existing condition of diabetes, high blood pressure or heart disease -- or who are already taking cholesterol lowering medication -- are candidates for the comprehensive VAP Test.
"This is a more advanced blood test that can far more accurately gauge your risk of heart disease," said Michael Ozner, M.D., F.A.C.C., of the Cardiovascular Prevention Institute of South Florida, and author of The Miami Mediterranean Diet. "The VAP Test not only offers a comprehensive assessment of cardiovascular risk, but also supplies vital information that can help you and your doctor formulate a customized disease-prevention program and measure its progress over time. This powerful diagnostic tool can help people take the steps necessary to avoid preventable health catastrophes -- like heart attack and stroke."
The VAP (Vertical Auto Profile) Test is the most accurate and
|SOURCE Atherotech, Inc.|
Copyright©2008 PR Newswire.
All rights reserved